<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prescribing Advice for GPs</title>
	<atom:link href="http://www.prescriber.org.uk/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.prescriber.org.uk</link>
	<description>An NHS Prescribing Advisers&#039; Blog</description>
	<lastBuildDate>Tue, 31 Aug 2010 08:29:14 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Ivabradine in Heart Failure?</title>
		<link>http://www.prescriber.org.uk/2010/08/ivabradine-in-heart-failure/</link>
		<comments>http://www.prescriber.org.uk/2010/08/ivabradine-in-heart-failure/#comments</comments>
		<pubDate>Tue, 31 Aug 2010 08:29:14 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=967</guid>
		<description><![CDATA[The Lancet has published the results of the SHIFT study which aimed to assess the effect of heart rate reduction using ivabradine (Procoralan&#174;) in patients with heart failure. The results of this study have been reported in the general media (BBC). The study recruited and treated 6,505 participants in symptomatic heart failure (NYHA II-IV) with [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/ivabradine-in-heart-failure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NICE Guidance &#8211; August 2010</title>
		<link>http://www.prescriber.org.uk/2010/08/nice-guidance-august-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/08/nice-guidance-august-2010/#comments</comments>
		<pubDate>Thu, 26 Aug 2010 08:07:44 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=966</guid>
		<description><![CDATA[The National Institute of Health and Clinical Excellence has published new guidance for the month of August 2010. This month there are three clinical guidelines that impact upon primary care. The Chronic Heart Failure guideline (QRG) is an update to the 2003 guideline. It covers the care and treatment of people with chronic heart failure [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/nice-guidance-august-2010/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Additional CKS Update &#8211; August 2010</title>
		<link>http://www.prescriber.org.uk/2010/08/additional-cks-update-august-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/08/additional-cks-update-august-2010/#comments</comments>
		<pubDate>Tue, 24 Aug 2010 10:11:21 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=965</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been further updated in August 2010 for the following clinical areas: Analgesia &#8211; mild-to-moderate pain (new) Corticosteroids &#8211; inhaled (new) Corticosteroids &#8211; oral (new) Corticosteroids &#8211; topical (skin, nose and eyes) (new) Action: Clinicians who see patients with any of these conditions may find the new and updated information useful [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/additional-cks-update-august-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MeReC Extra 46</title>
		<link>http://www.prescriber.org.uk/2010/08/merec-extra-46/</link>
		<comments>http://www.prescriber.org.uk/2010/08/merec-extra-46/#comments</comments>
		<pubDate>Thu, 19 Aug 2010 12:05:27 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=964</guid>
		<description><![CDATA[The National Prescribing Centre has published MeReC Extra 46 (PDF) which discusses the place in therapy for simvastatin 80mg daily and the increased risk of cancer observed with angiotensin receptor blockers (ARBs). The first section notes that earlier this year regulatory authorities drew attention to the increased risk of myopathy with simvastatin at a daily [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/merec-extra-46/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CKS Update &#8211; August 2010</title>
		<link>http://www.prescriber.org.uk/2010/08/cks-update-august-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/08/cks-update-august-2010/#comments</comments>
		<pubDate>Thu, 12 Aug 2010 14:20:30 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=963</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been updated in August 2010 for the following clinical areas: Breathlessness (new) Bronchiectasis (new) Epistaxix (new) Hepatitis A (new) Hepatitis B (new) Hypercalcaemia (new) LUTS in men, age-related (prostatism) Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/cks-update-august-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SMC Update &#8211; August 2010</title>
		<link>http://www.prescriber.org.uk/2010/08/smc-update-august-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/08/smc-update-august-2010/#comments</comments>
		<pubDate>Wed, 11 Aug 2010 10:05:29 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=962</guid>
		<description><![CDATA[The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines. Betamethasone medicated plaster (Betesil&#174;) has been rejected for the treatment of inflammatory skin disorders which do not respond to treatment with less potent corticosteroids. The economic analysis was not sufficiently robust. Aripiprazole (Abilify&#174;) has been accepted for restricted use for the treatment [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/smc-update-august-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Safety Update &#8211; August 2010</title>
		<link>http://www.prescriber.org.uk/2010/08/drug-safety-update-august-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/08/drug-safety-update-august-2010/#comments</comments>
		<pubDate>Tue, 10 Aug 2010 08:45:51 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=961</guid>
		<description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for August 2010 (PDF). This issue contains drug safety advice relating to QT and PR prolongation with saquinavir (Invirase&#174;). Clinicians should be aware of this issue and avoid using saquinavir in patients at high risk of cardiac arrhythmias, and in patients using [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/drug-safety-update-august-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Calcium supplements link to heart attacks</title>
		<link>http://www.prescriber.org.uk/2010/08/calcium-supplements-link-to-heart-attacks/</link>
		<comments>http://www.prescriber.org.uk/2010/08/calcium-supplements-link-to-heart-attacks/#comments</comments>
		<pubDate>Tue, 03 Aug 2010 14:07:57 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=960</guid>
		<description><![CDATA[The British Medical Journal has published the results of a meta-analysis that has identified an increased risk of heart attacks in people taking calcium supplements. This analysis has been reported in the general media (BBC). The analysis identified 15 trials, 5 with patient level data involving 8,151 participants with a median follow up period of [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/08/calcium-supplements-link-to-heart-attacks/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NICE Guidance &#8211; July 2010</title>
		<link>http://www.prescriber.org.uk/2010/07/nice-guidance-july-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/07/nice-guidance-july-2010/#comments</comments>
		<pubDate>Wed, 28 Jul 2010 08:44:06 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=959</guid>
		<description><![CDATA[The National Institute of Health and Clinical Excellence has published new guidance for the month of July 2010. This month there is a clinical guideline and public health guidance that have an impact on primary care. The clinical guideline details the care of adults with, or at risk of, delirium in hospital and in long-term [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/nice-guidance-july-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lipitor tablets getting smaller</title>
		<link>http://www.prescriber.org.uk/2010/07/lipitor-tablets-getting-smaller/</link>
		<comments>http://www.prescriber.org.uk/2010/07/lipitor-tablets-getting-smaller/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 12:58:52 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=958</guid>
		<description><![CDATA[The manufacturer of atorvastatin (Lipitor&#174;) has written to doctors informing them that smaller round tablets will replace the existing oval shaped tablets across the range of strengths for atorvastatin. A change in the manufacturing process has allowed the tablets to be made smaller. There will also be some changes to the tablet markings and the [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/lipitor-tablets-getting-smaller/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MeReC Bulletin &#8211; Advanced Wound Dressings</title>
		<link>http://www.prescriber.org.uk/2010/07/merec-bulletin-advanced-wound-dressings/</link>
		<comments>http://www.prescriber.org.uk/2010/07/merec-bulletin-advanced-wound-dressings/#comments</comments>
		<pubDate>Thu, 22 Jul 2010 12:12:06 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=957</guid>
		<description><![CDATA[The National Prescribing Centre (NPC) has published a MeReC Bulletin (PDF) that reviews the evidence for the evidence based prescribing for advanced wound dressings (A2RA). This bulletin reviews the evidence based for advanced wound dressings noting that lack of high-quality studies using clinically relevant endpoints. It is also noted that there is no robust clinical [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/merec-bulletin-advanced-wound-dressings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BNF for Children 2010-2011</title>
		<link>http://www.prescriber.org.uk/2010/07/bnf-for-children-2010-2011/</link>
		<comments>http://www.prescriber.org.uk/2010/07/bnf-for-children-2010-2011/#comments</comments>
		<pubDate>Wed, 21 Jul 2010 08:49:09 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=956</guid>
		<description><![CDATA[The British National Formulary for Children 2010-2011 has been updated, published and made available online. Hard copies can be ordered from the publishers however many NHS staff will receive a free hard copy through usual channels and can also access the online version at http://www.bnfc.nhs.uk. Update prescribing information in this revision include: Equivalent doses of [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/bnf-for-children-2010-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA to review ARB cancer link</title>
		<link>http://www.prescriber.org.uk/2010/07/fda-to-review-arb-cancer-link/</link>
		<comments>http://www.prescriber.org.uk/2010/07/fda-to-review-arb-cancer-link/#comments</comments>
		<pubDate>Mon, 19 Jul 2010 10:52:47 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=955</guid>
		<description><![CDATA[The Food and Drugs Administration (FDA) has announced that it is conducting a safety review of angiotensin receptor blockers (ARBs) after a recently published study suggested they may be associated with an increased risk of cancer. This announcement clarifies that: FDA&#8217;s review is ongoing and the Agency has not concluded that ARBs increase the risk [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/fda-to-review-arb-cancer-link/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SMC Update &#8211; July 2010</title>
		<link>http://www.prescriber.org.uk/2010/07/smc-update-july-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/07/smc-update-july-2010/#comments</comments>
		<pubDate>Thu, 15 Jul 2010 08:30:32 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=949</guid>
		<description><![CDATA[The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines. Sitagliptin (Januvia&#174;) has been accepted for restricted use as monotherapy to improve glycaemic control in patients with type 2 diabetes mellitus who are inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. Ketoprofen/omeprazole [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/smc-update-july-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CKS Update &#8211; July 2010</title>
		<link>http://www.prescriber.org.uk/2010/07/cks-update-july-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/07/cks-update-july-2010/#comments</comments>
		<pubDate>Wed, 14 Jul 2010 09:27:36 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=948</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been updated in July 2010 for the following clinical areas: Polycythaemia/erythrocytosis (new) Post-traumatic stress disorder (new) Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/cks-update-july-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EMA starts rosiglitazone review</title>
		<link>http://www.prescriber.org.uk/2010/07/ema-starts-rosiglitazone-review/</link>
		<comments>http://www.prescriber.org.uk/2010/07/ema-starts-rosiglitazone-review/#comments</comments>
		<pubDate>Mon, 12 Jul 2010 11:22:34 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=947</guid>
		<description><![CDATA[The European Medicines Agency has announced that it has started a review to determine whether new data on the risk of cardiovascular problems have an impact on the benefit-risk profile. Rosiglitazone is available in the European Union as a single agent (Avandia&#174;) and also in combination with metformin (Avandamet&#174;) and glimepiride (Avaglim&#174;). In 2008 a [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/ema-starts-rosiglitazone-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Influenza immunisation programme 2010/11 amendment</title>
		<link>http://www.prescriber.org.uk/2010/07/influenza-immunisation-programme-201011-amendment/</link>
		<comments>http://www.prescriber.org.uk/2010/07/influenza-immunisation-programme-201011-amendment/#comments</comments>
		<pubDate>Fri, 09 Jul 2010 10:54:05 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=946</guid>
		<description><![CDATA[The Chief Medical Officer at the Department of Health has reissued (PDF) an amended to colleagues within the NHS to provide details of the recommended influenza immunisation programme for 2010/11. The letter has been reissued to correct an error around the age below which children that have not previously received a seasonal influenza vaccine should [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/influenza-immunisation-programme-201011-amendment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Safety Update &#8211; July 2010</title>
		<link>http://www.prescriber.org.uk/2010/07/drug-safety-update-july-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/07/drug-safety-update-july-2010/#comments</comments>
		<pubDate>Thu, 08 Jul 2010 08:48:45 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=945</guid>
		<description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for July 2010 (PDF). This issue contains drug safety advice relating to the risk of accidental overdose with intravenous paracetamol (Perfalgan&#174;). While this product is not likely to be widely used in primary care, clinicians should be aware of the risks and [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/drug-safety-update-july-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STI rates among users of ED drugs</title>
		<link>http://www.prescriber.org.uk/2010/07/sti-rates-among-users-of-ed-drug/</link>
		<comments>http://www.prescriber.org.uk/2010/07/sti-rates-among-users-of-ed-drug/#comments</comments>
		<pubDate>Tue, 06 Jul 2010 12:37:24 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=944</guid>
		<description><![CDATA[The Annals of Internal Medicine has published the results of an analysis of a medical claims database of private, employer-based insurance in 44 large companies to assess the association between usage of medication to treat erectile dysfunction and sexually transmitted infections (STI). The analysis identified claims made between 1997 and 2006 for 1,410,806 men older [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/07/sti-rates-among-users-of-ed-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Additional CKS Update &#8211; June 2010</title>
		<link>http://www.prescriber.org.uk/2010/06/additional-cks-update-june-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/06/additional-cks-update-june-2010/#comments</comments>
		<pubDate>Wed, 30 Jun 2010 08:10:31 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=943</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been further updated in June 2010 for the following clinical areas: Crohn&#8217;s disease (new) Ulcerative colitis (new) Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/06/additional-cks-update-june-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Additional NICE Guidance &#8211; June 2010</title>
		<link>http://www.prescriber.org.uk/2010/06/additional-nice-guidance-june-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/06/additional-nice-guidance-june-2010/#comments</comments>
		<pubDate>Tue, 29 Jun 2010 08:40:17 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=942</guid>
		<description><![CDATA[The National Institute of Health and Clinical Excellence has published additional new guidance for the month of June 2010. Earlier this month guidance was issued relating to alcohol-use disorders and reducing alcohol related harm. NICE has now issued further public health guidance relating to quitting smoking in pregnancy and following childbirth (QRG) and prevention of [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/06/additional-nice-guidance-june-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mixtard 30 being discontinued</title>
		<link>http://www.prescriber.org.uk/2010/06/mixtard-30-being-discontinued/</link>
		<comments>http://www.prescriber.org.uk/2010/06/mixtard-30-being-discontinued/#comments</comments>
		<pubDate>Mon, 28 Jun 2010 08:06:33 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=940</guid>
		<description><![CDATA[The manufacturer of Mixtard&#174; 30 has announced that this product will be discontinued by the 31st December 2010 due to declining demand. Mixtard 30 is the only remaining Mixtard preparation since the discontinuation of the other presentations in 2007. Patients are being advised to contact their doctor or nurse to discuss treatment options. This move [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/06/mixtard-30-being-discontinued/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NICE Guidance &#8211; June 2010</title>
		<link>http://www.prescriber.org.uk/2010/06/nice-guidance-june-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/06/nice-guidance-june-2010/#comments</comments>
		<pubDate>Thu, 17 Jun 2010 10:54:25 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=939</guid>
		<description><![CDATA[The National Institute of Health and Clinical Excellence has published new guidance for the month of June 2010. This month there is a clinical guideline and public health guidance that have an impact on primary care. The clinical guideline details the management of physical complications arising from alcohol-use disorders in adults and young people while [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/06/nice-guidance-june-2010/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>CKS Update &#8211; June 2010</title>
		<link>http://www.prescriber.org.uk/2010/06/cks-update-june-2010/</link>
		<comments>http://www.prescriber.org.uk/2010/06/cks-update-june-2010/#comments</comments>
		<pubDate>Wed, 16 Jun 2010 08:32:27 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Other]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=938</guid>
		<description><![CDATA[Clinical Knowledge Summaries (CKS) has been updated in June 2010 for the following clinical areas: Haematospermia (new) Itch in pregnancy (new) Morton&#8217;s neuroma (new) Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/06/cks-update-june-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sinemet in short supply</title>
		<link>http://www.prescriber.org.uk/2010/06/sinemet-in-short-supply/</link>
		<comments>http://www.prescriber.org.uk/2010/06/sinemet-in-short-supply/#comments</comments>
		<pubDate>Tue, 15 Jun 2010 08:09:35 +0000</pubDate>
		<dc:creator>Matthew Robinson</dc:creator>
				<category><![CDATA[Prescribing Extra - Drugs]]></category>

		<guid isPermaLink="false">http://www.prescriber.org.uk/?p=937</guid>
		<description><![CDATA[The manufacturer of Sinemet&#174; and Sinemet CR&#174; has written to healthcare professionals advising of a global supply shortage of these products. Pharmacies have also been made aware of this situation. The letter indicates that the shortage is as a consequence of a change in the source of supply of levodopa, one of the active ingredients [...]]]></description>
		<wfw:commentRss>http://www.prescriber.org.uk/2010/06/sinemet-in-short-supply/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
